246 related articles for article (PubMed ID: 16127708)
1. Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain.
Rigby M; O'Donnell R; Rupniak NM
J Comp Neurol; 2005 Oct; 490(4):335-53. PubMed ID: 16127708
[TBL] [Abstract][Full Text] [Related]
2. Radioiodinated substance P, neurokinin A, and eledoisin bind predominantly in NK1 receptors in guinea pig lung.
Geraghty DP; Mussap CJ; Burcher E
Mol Pharmacol; 1992 Jan; 41(1):147-53. PubMed ID: 1370705
[TBL] [Abstract][Full Text] [Related]
3. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
4. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
5. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
6. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
7. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
8. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist.
Walpole CS; Brown MC; James IF; Campbell EA; McIntyre P; Docherty R; Ko S; Hedley L; Ewan S; Buchheit KH; Urban LA
Br J Pharmacol; 1998 May; 124(1):83-92. PubMed ID: 9630347
[TBL] [Abstract][Full Text] [Related]
9. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
11. Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain.
Dietl MM; Palacios JM
Brain Res; 1991 Jan; 539(2):211-22. PubMed ID: 1711392
[TBL] [Abstract][Full Text] [Related]
12. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain.
Saffroy M; Beaujouan JC; Torrens Y; Besseyre J; Bergström L; Glowinski J
Peptides; 1988; 9(2):227-41. PubMed ID: 2836823
[TBL] [Abstract][Full Text] [Related]
13. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
[TBL] [Abstract][Full Text] [Related]
14. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1.
Nakamura M; Ofuji K; Chikama T; Nishida T
Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288
[TBL] [Abstract][Full Text] [Related]
15. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide.
Ciucci A; Palma C; Manzini S; Werge TM
Br J Pharmacol; 1998 Sep; 125(2):393-401. PubMed ID: 9786514
[TBL] [Abstract][Full Text] [Related]
16. Effect of neurokinins on canine prostate cell physiology.
Walden PD; Marinese D; Srinivasan D; Tzoumaka E; Syyong HT; Ford AP; Bhattacharya A
Prostate; 2005 Jun; 63(4):358-68. PubMed ID: 15611996
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
18. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues, and in bone and dental hard tissue cells.
Fristad I; Vandevska-Radunovic V; Fjeld K; Wimalawansa SJ; Hals Kvinnsland I
Cell Tissue Res; 2003 Mar; 311(3):383-91. PubMed ID: 12658446
[TBL] [Abstract][Full Text] [Related]
19. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
Strigas J; Burcher E
Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
[TBL] [Abstract][Full Text] [Related]
20. Microvascular substance P binding to normal and inflamed rat and human synovium.
Walsh DA; Salmon M; Mapp PI; Wharton J; Garrett N; Blake DR; Polak JM
J Pharmacol Exp Ther; 1993 Nov; 267(2):951-60. PubMed ID: 7504102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]